CELG

Celgene Corporation News Headlines

$95.02
*  
0.32
0.34%
Get CELG Alerts
*Delayed - data as of Aug. 29, 2014  -  Find a broker to begin trading CELG now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Regeneron Pharmaceuticals' Pipeline Progress Raises Costs - Analyst Blog
8/29/2014 6:30:00 PM - Zacks.com

Today's Market: Red Hot Biotech And Big Pharma Names To Watch
8/29/2014 8:22:00 AM - Seeking Alpha

#PreMarket Primer: Thursday, August 28: Russia Implicated Further In Ukrainian Conflict
8/28/2014 7:00:47 AM - Benzinga

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog
8/27/2014 10:32:00 AM - Zacks.com

Why Celgene Stock Is Still A Good Investment Opportunity
8/26/2014 9:05:00 AM - Seeking Alpha

3 Reasons Celgene Corporation's Stock Could Fall
8/26/2014 8:49:24 AM - Motley Fool

#PreMarket Primer: Monday, August 25: Tension In Ukraine Runs High On Independence Day
8/25/2014 7:23:25 AM - Benzinga

Data on Celgene's Revlimid Published in Oncology Journal - Analyst Blog
8/22/2014 5:35:00 PM - Zacks.com

Cramer's Mad Money - 12 Stocks That Have Performed Better Than Google (8/21/14)
8/22/2014 6:22:00 AM - Seeking Alpha

Bull of the Day: Epizyme (EPZM) - Bull of the Day
8/22/2014 1:31:00 AM - Zacks.com

Bristol-Myers, Celgene Pair Up for Oncology Combo Treatments - Analyst Blog
8/21/2014 5:20:00 PM - Zacks.com

Bull of the Day: Epizyme (EPZM) - Bull of the Day
8/21/2014 12:31:00 PM - Investopedia

#PreMarket Primer: Thursday, August 21: Tension Between Russia And The West Mounting
8/21/2014 6:40:45 AM - Benzinga

Emergent BioSolutions, MorphoSys Tie Up on Cancer Candidate - Analyst Blog
8/20/2014 6:08:00 PM - Zacks.com

Biogen Strengthens MS Portfolio with Plegridy FDA Approval - Analyst Blog
8/19/2014 1:20:00 PM - Zacks.com

Noteworthy ETF Outflows: IYH, AMGN, BIIB, CELG
8/19/2014 11:03:17 AM - BNK Invest

Celgene's Phase II Trial Of REVLIMID With R-CHOP Shows Positive Results
8/19/2014 7:53:00 AM - RTT News

3 Reasons Celgene Corporation's Stock Could Rise
8/18/2014 12:58:18 PM - Motley Fool

Taking Profits From Netflix And Putting Them To Work In Celgene
8/18/2014 12:41:00 PM - Seeking Alpha

Jim Cramer Answers Twitter (TWTR) Questions on Walmart (WMT), Yelp (YELP), Kinder Morgan (KMI) and More
8/18/2014 12:40:00 PM - TheStreet

Epizyme Holds A Key To A Potential Blockbuster Drug For Hematological Cancers
8/18/2014 11:24:00 AM - Seeking Alpha

#PreMarket Primer: Thursday, August 14: Investors Are Unfazed By Weak Retail Sales
8/14/2014 7:20:53 AM - Benzinga

ETF Outlook: SPDR S&P Biotech ETF (XBI)
8/13/2014 8:22:34 AM - Marc Chaikin

Cramer's Mad Money - The Most Bountiful M&A Year I Have Seen (8/11/14)
8/12/2014 5:42:00 AM - Seeking Alpha

Cramer's Mad Money - 12 Things To Watch In The Week Ahead (8/8/14)
8/11/2014 6:48:00 AM - Seeking Alpha